Brought to you by 
Nippon Roche acquires majority of Chugai
29 Sep 2021
Executive Summary
Roche's Japanese subsidiary Nippon Roche and Chugai Pharmaceutical Co. will merge to form an R&D-driven Japanese pharmaceutical company, which will leverage the strengths of both. The new company will retain the Chugai name and continue its listing on the Tokyo Stock Exchange.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nippon Roche acquires majority of Chugai
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice